All Stories

  1. A Low-Cost Wireless Body Area Network for Human Activity Recognition in Healthy Life and Medical Applications
  2. Exploring Outcome Priorities and Real-Life Management of Chemotherapy-Induced Peripheral Neurotoxicity: A Survey of the Italian Association for the Study of Pain members
  3. Effect of Upper Limb Motor Rehabilitation on Cognition in Parkinson’s Disease: An Observational Study
  4. Cerebellar involvement associated with immune checkpoint inhibitors: A systematic review
  5. IncobotulinumtoxinA Injection for Treating Children with Idiopathic Toe Walking: A Retrospective Efficacy and Safety Study
  6. Wearables, sensors, and smart devices for the detection and monitoring of chemotherapy‐induced peripheral neurotoxicity: Systematic review and directions for future research
  7. D2/D3 Receptor Agonism: Paving the Way for a New Therapeutic Target for Taste Disorders in Parkinson’s Disease and Other Conditions?
  8. Brain Structural and Functional Alterations in Multiple Sclerosis-Related Fatigue: A Systematic Review
  9. Pharmacological Treatment of Pain and Agitation in Severe Dementia and Responsiveness to Change of the Italian Mobilization–Observation–Behavior–Intensity–Dementia (I-MOBID2) Pain Scale: Study Protocol
  10. Rehabilitation, exercise, and related non-pharmacological interventions for chemotherapy-induced peripheral neurotoxicity: systematic review and evidence-based recommendations
  11. Combining Low-Dose Radiation Therapy and Magnetic Resonance Guided Focused Ultrasound to Reduce Amyloid-β Deposition in Alzheimer’s Disease
  12. Olfaction in patients with Parkinson’s disease: a new threshold test analysis through turning points trajectories
  13. Remote clinical trials: A timely opportunity for a virtual reality approach and its potential application in neurology
  14. Electrical Stimulation of Injected Muscles to Boost Botulinum Toxin Effect on Spasticity: Rationale, Systematic Review and State of the Art
  15. Comment on “The association between pain and impulse control behaviours in Parkinson's disease”
  16. COVID-19 and related symptoms in patients under disulfiram for alcohol use disorder
  17. Adult attention-deficit/hyperactivity disorder symptoms, cognitive dysfunction and quality of life in high-dose use of benzodiazepine and Z-drug
  18. Smoking-related cue reactivity in a virtual reality setting: association between craving and EEG measures
  19. Pattern of treatment of behavioural and psychological symptoms of dementia and pain: evidence on pharmacoutilization from a large real-world sample and from a centre for cognitive disturbances and dementia
  20. Regulation of microRNAs in Satellite Cell Renewal, Muscle Function, Sarcopenia and the Role of Exercise
  21. Risk of hospitalization associated with benzodiazepines and z‐drugs in Italy: a nationwide multicentre study in emergency departments—comment
  22. Toward a Wearable System for Predicting Freezing of Gait in People Affected by Parkinson's Disease
  23. Selective atrophy of the brachialis muscle in neuralgic amyotrophy: ultrasound imaging of fascicular nerve damage
  24. Vertebral Artery Fenestration Mimicking Acute Dissection
  25. Towards a Redefinition of Cognitive Frailty
  26. Pharmacological treatment of opioid-induced constipation: moving ahead to new targets
  27. Association between Adult Attention Deficit/Hyperactivity Disorder and Intravenous Misuse of Opioid and Benzodiazepine in Patients under Opioid Maintenance Treatment: A Cross-Sectional Multicentre Study
  28. Adult Attention-Deficit/Hyperactivity Disorder and Quality of Life in High-Dose Benzodiazepine and Related Z-Drug Users
  29. An Indoor Therapeutic Garden for Behavioral Symptoms in Alzheimer’s Disease: A Randomized Controlled Trial
  30. Chemotherapy‐induced peripheral neurotoxicity: A multifaceted, still unsolved issue
  31. Taxane and epothilone‐induced peripheral neurotoxicity: From pathogenesis to treatment
  32. Immune checkpoint inhibitors‐induced neuromuscular toxicity: From pathogenesis to treatment
  33. Platinum‐induced peripheral neurotoxicity: From pathogenesis to treatment
  34. Nerve size correlates with clinical severity in Charcot–Marie–Tooth disease 1A
  35. High-dose lormetazepam dependence: strange case of Dr. Jekyll and Mr. Hyde—reply
  36. Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings
  37. OnabotulinumtoxinA Reduces Temporal Pain Processing at Spinal Level in Patients with Lower Limb Spasticity
  38. Improvement of motor performance in children with cerebral palsy treated with exoskeleton robotic training: A retrospective explorative analysis
  39. High-dose lormetazepam dependence: strange case of Dr. Jekyll and Mr. Hyde
  40. Olfaction and taste in Parkinson’s disease: the association with mild cognitive impairment and the single cognitive domain dysfunction
  41. Intrapretuvalisuse of Methadone, Buprenorphine and Buprenorphine-Naloxone in Patients Under Opioid Maintenance Treatment: A Cross-Sectional Multicentre Study
  42. Neuropsychological testing
  43. MoCA for cognitive screening in Parkinson's disease: Beware of floor effect
  44. The spectrum of Charcot-Marie-Tooth disease due to myelin protein zero: An electrodiagnostic, nerve ultrasound and histological study
  45. Erectile dysfunction and quality of life in men receiving methadone or buprenorphine maintenance treatment. A cross-sectional multicentre study
  46. Low risk of seizures with slow flumazenil infusion and routine anticonvulsant prophylaxis for high-dose benzodiazepine dependence
  47. Screening for adult attention deficit/hyperactivity disorder in high-dose benzodiazepine dependent patients
  48. Diagnosing mild cognitive impairment in Parkinson’s disease: which tests perform best in the Italian population?
  49. Botulinum neurotoxin type A for the treatment of pain: not just in migraine and trigeminal neuralgia
  50. Determinants of Quality of Life in High-Dose Benzodiazepine Misusers
  51. The burden of chronic pain and the role of neurorehabilitation: consensus matters where evidence is lacking
  52. Pharmacological treatment for familial amyloid neuropathy
  53. Multifocal cognitive dysfunction in high-dose benzodiazepine users: a cross-sectional study
  54. Electrodiagnosis of Lesions of Median and Ulnar Nerve Hand Sensory Branches
  55. The Diagnostic Value of Nerve Ultrasound in an Atypical Palmar Cutaneous Nerve Lesion
  56. Working memory in healthy aging and in Parkinson’s disease: evidence of interference effects
  57. The Italian Consensus Conference on Pain in Neurorehabilitation: rationale and methodology
  58. Psychological Considerations in the Assessment and Treatment of Pain in Neurorehabilitation and Psychological Factors Predictive of Therapeutic Response: Evidence and Recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation
  59. Psychological Treatments and Psychotherapies in the Neurorehabilitation of Pain: Evidences and Recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation
  60. Pathophysiology of Motor Dysfunction in Parkinson’s Disease as the Rationale for Drug Treatment and Rehabilitation
  61. How to diagnose neuropathic pain? The contribution from clinical examination, pain questionnaires and diagnostic tests
  62. An electrodiagnostic technique for assessing palmar proper digital nerves of the hand: Normative data and clinical application
  63. Isolated musculocutaneous nerve injury in a kickboxer
  64. Damage to the Median and Ulnar Nerves After a Snake Bite
  65. Unexpected Inching Explained by an Ulnar Nerve Anatomic Variant Documented by Sonography
  66. Sunderland's median nerve fascicular anatomy revisited by ultrasound
  67. Co-Occurrence of the C9ORF72 Expansion and a Novel GRN Mutation in a Family with Alternative Expression of Frontotemporal Dementia and Amyotrophic Lateral Sclerosis
  68. The Association between Serum Cytokines and Damage to Large and Small Nerve Fibers in Diabetic Peripheral Neuropathy
  69. Screening for Mild Cognitive Impairment in Parkinson’s Disease: Comparison of the Italian Versions of Three Neuropsychological Tests
  70. Cognition and emotional decision-making in chronic low back pain: an ERPs study during Iowa gambling task
  71. Painful Legs and Moving Toes Syndrome: Putative Underlying Pathophysiology as a Hint for Combined Pharmacological Treatment?
  72. Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDP
  73. Diagnostic and Therapeutic Pitfalls in Considering Chronic Pain as a Disease
  74. Relationship Between Ultrasonographic, Electromyographic, and Clinical Parameters in Adult Stroke Patients With Spastic Equinus: An Observational Study
  75. Effect of 5% Lidocaine Medicated Plaster on Pain Intensity and Paroxysms in Classical Trigeminal Neuralgia
  76. Decision and dopaminergic system: an ERPs study of Iowa gambling task in Parkinson’s disease
  77. Robot-assisted vs. sensory integration training in treating gait and balance dysfunctions in patients with multiple sclerosis: a randomized controlled trial
  78. Periodic thigh pain from radicular endometriosis
  79. Anti-N-Methyl-D-Aspartate Receptor Encephalitis Causing a Prolonged Depressive Disorder Evolving to Inflammatory Brain Disease
  80. Immunoglobulin G for the Treatment of Chronic Pain: Report of an Expert Workshop
  81. Letter to the Editor
  82. Robot-assisted arm training in patients with Parkinson’s disease: a pilot study
  83. Association between Severe Upper Limb Spasticity and Brain Lesion Location in Stroke Patients
  84. Long-Term Response of Neuropathic Pain to Intravenous Immunoglobulin in Relapsing Diabetic Lumbosacral Radiculoplexus Neuropathy. A Case Report
  85. No evidence of a neuropathic origin in hemiplegic shoulder pain
  86. Neuropathic pain: diagnosis and treatment
  87. Botulinum Toxin Type A Injection Into the Gastrocnemius Muscle for Spastic Equinus in Adults With Stroke
  88. Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial
  89. A Randomized, Double Blind, Controlled Trial of Intravenous Immunoglobulins Versus Intravenous Methylprednisolone in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (IMC Study) (S07.001)
  90. Accuracy of botulinum toxin type A injection into the gastrocnemius muscle of adults with spastic equinus: Manual needle placement and electrical stimulation guidance compared using ultrasonography
  91. Abnormalities of intraterritorial and extraterritorial sensory processing in carpal tunnel syndrome and their pathophysiological significance: A comment on the paper by Schmid et al. (Eur J Pain, 2011)
  92. Unilateral fixed mydriasis: an uncommon presentation of temporal lobe epilepsy
  93. P4.20 Pain response to repeated administration of intravenous immunoglobulin in a patient with diabetic lumbosacral radiculoplexus neuropathy. Evidence for proinflammatory cytokine activation
  94. P4.21 The association of ulnar nerve conduction changes with carpal tunnel syndrome. A multivariate analysis study
  95. Immediate versus delayed electrical stimulation boosts botulinum toxin effect: A pilot study
  96. Median Nerve Small- and Large-Fiber Damage in Carpal Tunnel Syndrome: A Quantitative Sensory Testing Study
  97. Central sensitization and sensory symptoms spread in carpal tunnel syndrome: A response to Ginanneschi and Rossiʼs letter on the relationship between central plastic changes and sensory symptoms in peripheral entrapment neuropathies
  98. Guillain-Barré syndrome after short-course efalizumab treatment
  99. Recurrent transitory ischaemic attacks with skin lesions, arthralgia and myalgia should prompt suspicion of atrial myxoma
  100. Central sensitization in carpal tunnel syndrome with extraterritorial spread of sensory symptoms
  101. Muscular pain in Parkinson's disease and nociceptive processing assessed with CO2 laser-evoked potentials
  102. P2.093 Switch from subcutaneous apomorphine to intraduodenal levodopa offers additional beneflt on motor fluctuations and dyskinesias in advanced Parkinson's disease
  103. Intravenous Immunoglobulin for the Treatment of Diabetic Lumbosacral Radiculoplexus Neuropathy
  104. Ulnar nerve impairment at the wrist does not contribute to extramedian sensory symptoms in carpal tunnel syndrome
  105. 132 ULNAR NERVE IMPAIRMENT AT THE WRIST IS NOT CORRELATED WITH EXTRAMEDIAN SPREAD OF SENSORY SYMPTOMS IN CARPAL TUNNEL SYNDROME
  106. Hyperalgesia and laser evoked potentials alterations in hemiparkinson: Evidence for an abnormal nociceptive processing
  107. Pain and motor function in carpal tunnel syndrome
  108. The effect of repetitive transcranial magnetic stimulation on motor performance, fatigue and quality of life in amyotrophic lateral sclerosis
  109. Cingulate Gyrus Tumor Presenting as Panic Attacks
  110. Belly dancer's myoclonus and chronic abdominal pain: Pain-related dysinhibition of a spinal cord central pattern generator?
  111. Proximal pain in patients with carpal tunnel syndrome: a clinical-neurophysiological study
  112. 178 INTRAVENOUS IMMUNOGLOBULINS TREATMENT IMPROVES PAIN IN DIABETIC LUMBOSACRAL RADICULOPLEXUS NEUROPATHY
  113. 215 EXTRAMEDIAN AND PROXIMAL SPREAD OF SENSORY SYMPTOMS IN CARPAL TUNNEL SYNDROME: A CLINICAL-NEUROPHYSIOLOGICAL STUDY
  114. 2.222 Continuous dopaminergic stimulation in advanced PD. Switching from apomorphine to duodopa: Which treatment is better?
  115. FC39.1 The use of intravenous immunoglobulins for the treatment of diabetic lumbosacral radiculoolexus neuropathy
  116. FC19.4 The spread of sensory symptoms outside the median territory in carpal tunnel syndrome indicates the presence of pain-related mechanisms
  117. Extra-median spread of sensory symptoms in carpal tunnel syndrome suggests the presence of pain-related mechanisms
  118. Sensorimotor integration to cutaneous afferents in humans: the effect of the size of the receptive field
  119. Abnormalities of sensory processing and sensorimotor interactions in secondary dystonia: A neurophysiological study in two patients
  120. A case of oligosymptomatic botulism. The role of single-fiber EMG in early diagnosis
  121. Modulation of motor cortex excitability after upper limb immobilization
  122. Enhanced intracortical inhibition in cerebellar patients
  123. Stimulus-response properties of motor system in patients with cerebellar ataxia
  124. Motor Responses to Afferent Stimulation in Juvenile Myoclonic Epilepsy
  125. Abnormal sensorimotor integration is related to disease severity in Parkinson's disease: A TMS study
  126. Abnormal cutaneomotor integration in patients with cerebellar syndromes: a transcranial magnetic stimulation study
  127. Focal hand dystonia after cervical whiplash injury
  128. Changes in motor cortex inhibition over time in patients with amyotrophic lateral sclerosis
  129. Abnormal somatotopic arrangement of sensorimotor interactions in dystonic patients
  130. Different mechanisms contribute to motor cortex hyperexcitability in amyotrophic lateral sclerosis
  131. Hyperexcitable cortical responses in progressive myoclonic epilepsy: A TMS study
  132. Cutaneomotor integration in human hand motor areas: somatotopic effect and interaction of afferents
  133. Transient inhibition of the human motor cortex by capsaicin-induced pain. A study with transcranial magnetic stimulation